http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110638812-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 |
| filingDate | 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110638812-B |
| titleOfInvention | New application of sesquiterpenoids in reducing uric acid |
| abstract | The invention belongs to the field of medicines, and in particular relates to a new application of sesquiterpenoids in reducing uric acid. The sesquiterpene compound has a structure shown in formula (I): , R 1 , R 2 , R 3 , and R 4 are as defined in the description of the present invention. The present invention finds through the animal model of hyperuricemia that the sesquiterpene compound of the present invention promotes the excretion of uric acid in vivo, has a significant effect of reducing uric acid, and can be used as a potential drug for reducing uric acid or treating gout. |
| priorityDate | 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.